Fortress Biotech, Inc.
- SEC CIK
- 0001429260
No open-market purchases or sales filed in the past year.
Current role at each company
- ATXI Avenue Therapeutics, Inc.10% Owneras of Jan 6, 2026
- MBIO Mustang Bio, Inc.10% Owneras of Jan 5, 2026
- CKPT Checkpoint Therapeutics, Inc.10% Owneras of Jun 3, 2025
- DERM Journey Medical Corp10% Owneras of May 31, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fortress Biotech, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CKPT Checkpoint Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 (view filing) | May 29 | 5 daysLate | Fortress Biotech, Inc.10% Owner | SSaleCOMMON STOCK, PAR VALUE $0.0001 | −100.0K | $1.29 | −$129.0K | −1.6%6.12M after |
ATXI Avenue Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | Fortress Biotech, Inc.10% Owner | PPurchase | +418.4K | $0.72 | +$301.3K | +68.1%1.03M after |